839 related articles for article (PubMed ID: 7595225)
1. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
[TBL] [Abstract][Full Text] [Related]
3. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
6. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
7. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells.
Björck P; Banchereau J; Flores-Romo L
Int Immunol; 1997 Mar; 9(3):365-72. PubMed ID: 9088975
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
Schattner EJ; Friedman SM; Casali P
Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes.
Genestier L; Meffre G; Garrone P; Pin JJ; Liu YJ; Banchereau J; Revillard JP
Blood; 1997 Jul; 90(2):726-35. PubMed ID: 9226173
[TBL] [Abstract][Full Text] [Related]
11. CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.
Kim D; Hur DY; Kim YS; Lee K; Lee Y; Cho D; Kang JS; Kim YI; Hahm E; Yang Y; Yoon S; Kim S; Lee WB; Park HY; Kim YB; Hwang YI; Chang KY; Lee WJ
Hum Immunol; 2002 Jul; 63(7):576-87. PubMed ID: 12072193
[TBL] [Abstract][Full Text] [Related]
12. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.
Galibert L; Burdin N; de Saint-Vis B; Garrone P; Van Kooten C; Banchereau J; Rousset F
J Exp Med; 1996 Jan; 183(1):77-85. PubMed ID: 8551247
[TBL] [Abstract][Full Text] [Related]
13. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells.
Tong AW; Seamour B; Chen J; Su D; Ordonez G; Frase L; Netto G; Stone MJ
Leuk Lymphoma; 2000 Feb; 36(5-6):543-58. PubMed ID: 10784400
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
[TBL] [Abstract][Full Text] [Related]
16. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
17. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
[TBL] [Abstract][Full Text] [Related]
18. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.
Cleary AM; Fortune SM; Yellin MJ; Chess L; Lederman S
J Immunol; 1995 Oct; 155(7):3329-37. PubMed ID: 7561026
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
